Search results
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
Zacks via Yahoo Finance· 1 day agoRecently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes...
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 7 hours agoThat's an important selling point many biotech companies can offer investors. With that as a...
CRISPR-Crafted Cuisine: How Genetic Engineering Is Changing What We Eat
SciTechDaily· 2 days agoWith animal-free dairy products and convincing vegetarian meat substitutes already on the market,...
John Leonard
Time Magazine· 6 hours agoFind out why John Leonard is on the TIME100 Health list.
Peter Marks
Time Magazine· 6 hours agoIn 2023, the U.S. Food and Drug Administration (FDA) brought a number of never-before-seen treatments to market, approving the first gene therapies using...
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
InvestorPlace· 8 hours agoPay close attention to gene editing stocks. All in an effort to help treat sickle-cell anemia,...
‘ChatGPT for CRISPR’ creates new gene-editing tools
Nature· 4 days agoSome of the AI-designed gene editors could be more versatile than those found in nature.
Can CRISPR-Cas gene editing tech fight antimicrobial resistance?
Investing.com· 5 days agoCan CRISPR-Cas gene editing tech fight antimicrobial resistance?
CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note
Zacks via Yahoo Finance· 6 days agoCRISPR Therapeutics AG (CRSP) closed the latest trading day at $53.91, indicating a +0.34% change...
A New Delivery System Offers Hope for Cystic Fibrosis
The Scientist· 1 day agoIn a study published in Nature Communications, scientists reported a novel strategy to deliver the ...
